MTOR and obesity due to melanocortin 4 receptor deficiency: Counter intuitively, we observed that obesity was associated primarily with increased predicted sensitivity with GDSC drugs including those targeting DNA replication and MTOR, but not metabolism pathways which indicates that not all CRC pathways were equally affected.